ArisGlobal participated in the Breakthrough 2027 conference in London from 2 to 3 March 2027.

ArisGlobal is an AI-first technology company at the forefront of life sciences and the creator of LifeSphere®, the platform trusted by hundreds of life sciences organizations, CROs, and health authorities to advance drug development and operationalize AI across Safety, Regulatory, Medical Affairs, and Quality. At the core of the LifeSphere suite is NavaX, ArisGlobal's next-generation cognitive computing engine, bringing production-ready AI directly into operational workflows across the R&D enterprise. NavaX powers a growing range of applications across pharmacovigilance — from case intake and coding to signal detection, document generation, and multilingual processing — helping organizations reduce manual effort, accelerate timelines, and improve data quality, consistency, and compliance. ArisGlobal is proud to be the technology partner of choice for hundreds of global life sciences organizations and leading regulatory bodies, including 60% of Top 10 pharma organizations globally. As the industry moves from AI experimentation to enterprise-scale adoption, ArisGlobal is helping organizations deploy AI with confidence.